Showing results (251-260 of 831) with videos related to

Sort By:
Pageof 84
Cancer|October 30, 2003
Chromosomal abnormalities in Philadelphia chromosome-negative metaphases appearing during imatinib mesylate therapy in patients with Philadelphia chromosome-positive chronic myelogenous leukemia in chronic phaseJorge Medina, Hagop Kantarjian, Moshe Talpaz, et al.
Clinical Lymphoma, Myeloma & Leukemia|August 6, 2011
Pilot study of bortezomib for patients with imatinib-refractory chronic myeloid leukemia in chronic or accelerated phaseFabio P S Santos, Hagop Kantarjian, David McConkey, et al.
Leukemia & Lymphoma|July 16, 2005
The degree of bone marrow fibrosis in chronic myelogenous leukemia is not a prognostic factor with imatinib mesylate therapyHagop M Kantarjian, Carlos E Bueso-Ramos, Moshe Talpaz, et al.
Experimental Hematology|May 9, 2009
Proteomics-based prediction of clinical response in acute myeloid leukemiaMaher Albitar, Steven J Potts, Francis J Giles, et al.
Cancer|June 12, 2009
Dynamics and management of cytopenias associated with dasatinib therapy in patients with chronic myeloid leukemia in chronic phase after imatinib failureAlfonso Quintás-Cardama, Fabio Pires De Souza Santos, Hagop Kantarjian, et al.
Leukemia & Lymphoma|March 4, 2010
Late relapses in acute myeloid leukemia: analysis of characteristics and outcomeDushyant Verma, Hagop Kantarjian, Stefan Faderl, et al.
Cancer|March 29, 2002
The clinical and diagnostic relevance of CD23 expression in the chronic lymphoproliferative diseaseFrancesco DiRaimondo, Maher Albitar, Yang Huh, et al.
Leukemia Research|December 25, 2007
An immunological method for the detection of BCR-ABL fusion protein and monitoring its activationIman Jilani, Hagop Kantarjian, Homan Faraji, et al.
Haematologica|August 6, 2002
A phase I study of idarubicin dose escalation with amisfostine and high-dose cytarabine in patients with relapsed acute myelogenous leukemia and myelodysplastic syndromesGuillermo Garcia-Manero, Stefan Faderl, Francis Giles, et al.
Cancer|June 22, 2010
Outcome of patients with myelodysplastic syndrome after failure of decitabine therapyElias Jabbour, Guillermo Garcia-Manero, Nicolas Batty, et al.
Pageof 84